RecallDepth
Class III Terminated

Clonazepam Tablets, USP, 1.0 mg, packaged in a 100- count unit dose box of 10 x 10 blister cards, Rx only, Manufactured by Mylan Pharmaceuticals Inc, Morgantown, WV, 26505, NDC 51079-882-20

Company
Mylan Institutional, Inc. (D.B.A. Udl Laboratories)
Recall Initiated
September 28, 2016
Posted
November 16, 2016
Recall Number
D-0136-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
46,472 unit dose blister cards (10 cards of 10 tablets each)
Firm Location
Rockford, IL, United States

Reason for Recall

Failed Impurities/Degradation Specifications: out of specification result for Clonazepam Related Compound (RC) A (a known impurity) at 16 month timepoint.

Distribution

Nationwide

Lot / Code Info

Lot#: 3061784, Exp 11/16; 3067656, Exp 12/16; 3074902, Exp 08/17

More recalls by Mylan Institutional, Inc. (D.B.A. Udl Laboratories)

View all recalls by this company →

Other recent Class III Drug recalls